NEW YORK ( TheStreet) -- Parexel International Corporation (Nasdaq: PRXL) hit a new 52-week high Tuesday as it is currently trading at $26.96, above its previous 52-week high of $26.89 with 87,114 shares traded as of 11 a.m. ET. Average volume has been 662,600 shares over the past 30 days. Parexel International has a market cap of $1.6 billion and is part of the health care sector and health services industry. Shares are up 20.6% year to date as of the close of trading on Monday. PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications, and consulting services, as well as advanced technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 26.1, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 16.7.
Practice your PRXL trading strategies and win cash in our stock game.
TheStreet Ratings rates Parexel International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Parexel International Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.